• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Implements the eCTD of Drug Application

NMPA Implements the eCTD of Drug Application

Tuesday, 23 November 2021 / Published in News, NMPA Registration in China, Pharmaceuticals & DMF

NMPA Implements the eCTD of Drug Application

In order to improve the management of the electronic filing for drug registration applications, and to enhance the internet-based drug regulation service, the NMPA (National Medical Products Administration) decided (No.119-2021) to fully develop and promote the filing system of the electronic Common Technical Document for Drugs (eCTD) on September 29, 2021.  

Starting from December 29, 2021, the registration of chemical drugs which belong to the class 1 and class 5.1, and the registration of class 1 therapeutic biological products and class 1 preventive biological products can be conducted through this eCTD filing system.

Scope of application

The eCTD is applicable to the clinical trial application, marketing authorization application, re-registration application, and other supplementary applications for chemical drugs and biological products. In vitro diagnostic reagents which are managed as biological product are not included.

Basic requirements

  • Applicants should prepare and submit an eCTD CD-ROM containing the application files, according to the requirements for the eCTD technical documents, and submit the corresponding paper materials within 5 work days after the acceptance of the eCTD CD-ROM. If applicants do not submit paper materials within the prescribed time, the registration process will be terminated. At the same time, the applicant should promise that the submitted electronic materials are completely consistent with the content of the paper materials. Any problems arising from the consistency of the materials shall be borne by the applicant. The applicant shall also ensure the authenticity of the submitted eCTD application materials.
  • After the applicant submits the application materials by using the eCTD, all subsequent submissions, including preliminary supplementary submission and technical supplementary submission, etc., should be also conducted through the eCTD, the paper materials will no longer be accepted.

Specific requirements

  • The choice of storage medium and the requirements for disc-burning – If there are too many application materials and thus the capacity demand is large, the applicant should use one DVD instead of multiple CDs. If applicants must use multiple discs, they shall split the content according to the different modules. It is recommended that applicants use storage media with faster read and write speeds to improve the reading speed of the application materials, such as 16x DVD discs. In order to reduce the security risk brought by the storage medium during delivery and transportation, the storage media submitted to the regulatory agency will not be returned to the applicant.
  • Disc cover information – Applicants should fill in and then print the cover information for the disc from the online drug application system of NMPA. It should be pasted on the surface of the disc box and submitted along with the application materials.
  • Virus check – Applicants need to perform virus inspection on the submitted eCTD materials in advance and provide a virus check statement in an explanatory letter. After receiving the application materials, a virus check will be carried out later by the NMPA. If a virus is found, the application materials will be rejected.
  • Technical Verification – After all the eCTD application materials are prepared, applicants should use a professional verification software (Applicants can download a free version of the verification software from the Pharmacovigilance website of the CDE) to verify the application materials. The verification software will generate a corresponding report after the verification is completed. The verification report will indicate whether there are “errors” in the materials and inform the applicants of possible problems through “warnings”. If the report shows “error”, it means the corresponding standard marked is a key standard that must be followed. Any “errors” will lead to rejection of the application. If the report shows “warning”, it means this standard marked is a recommended standard. It is recommended that the applicants solve this problem before the official submission.

By Sun Jinlin. Contact Cisema if you would like to learn more.

What you can read next

China medical device registration review guidelines
China medical device registration review guidelines released for 27 products in September 2022
Regulatory Updates for Implant Products in September 2021
15 Years in China Business

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.